We evaluated whether immune activation (IA) and microbial translocation (MT) might play a role in accelerating liver disease progression in HIV-HBV/HCV co-infected patients.
Marchetti, G., Cozzi Lepri, A., Tincati, C., Calcagno, A., CECCHERINI SILBERSTEIN, F., De Luca, A., et al. (2014). Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: Results from the Icona Foundation study. BMC INFECTIOUS DISEASES, 14(1), 79 [10.1186/1471-2334-14-79].
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: Results from the Icona Foundation study
CECCHERINI SILBERSTEIN, FRANCESCA;
2014-02-12
Abstract
We evaluated whether immune activation (IA) and microbial translocation (MT) might play a role in accelerating liver disease progression in HIV-HBV/HCV co-infected patients.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
2014_Immune activation and microbial translocation_marchetti.pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
647.45 kB
Formato
Adobe PDF
|
647.45 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.